4Gamelin L,Boisdron C M,Delva R,et al.A retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced colorectal cancer[J].Clin Cancer Res,2004,10(2):4055.
5Levi F,Misset J L.Brienza S.et al.Achronopharmacologic phase lⅢ Clinical trial with 5-fluorouracil,folinic acid and oxaliplatin using an ambulatory multichannel programmable pump.High antitumor effectives against metastatic colorectal cancer[J].Cancer,1992,69:893.
2Di Francia R,Siesto R S,Valente D,et al.Current strategies to minimize toxicity of oxaliplatin:selection of pharmacogenomic panel tests[J].Anti-cancer drugs,2013,24(10):1069.
3Martins I,Kepp O,Schlemmer F,et al.Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress[J].Oncogene,2011,30(10):1147.
4Lei S,Jia L,Lou Y.Study on compound herbal medicine LC07 treating chemotherapy-induced peripheral neuropathy[C]//ASCO Annual Meeting Proceedings,2008,26(15_suppl):20735.
5Grolleau F,Gamelin L,Boisdron-Celle M,et al.A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels[J].Journal of Neurophysiology,2001,85(5):2293.
6Basso M,Modoni A,Spada D,et al.Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity[J].Cancer chemotherapy and pharmacology,2011,67(5):1179.
7Gamelin L,Capitain O,Morel A,et al.Predictive factors of oxaliplatin neurotoxicity:the involvement of the oxalate outcome pathway[J].Clinical Cancer Research,2007,13(21):6359.
8Cassidy J,Misset J L.Oxaliplatin-related side effects:characteristics and management[C]//Seminars in oncology.WB Saunders,2002,29(5):11.
